肝内胆管癌（ICC）作为第二大肝脏原发恶性肿瘤，其发病率在全球范围内呈上升趋势。当前，手术切除是 ICC 获得长期生存的唯一可能治愈手段，但 ICC 侵袭性强、恶性程度极高，数据显示，即便接受了根治性切除，超 50% 的患者仍会在术后两年内复发，5 年总生存（OS）率仅为 25%-30%[1-2]。尤其是对于伴有肿瘤直径 ＞5 cm、多灶性切除、血管侵犯、肝门急性转移以及血清 CA19-9 水平升 ...

The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic ...

Compass Therapeutics' tovecimig shows promise in biliary tract cancer with a 17.1% response rate, but further survival data is crucial for potential approval. CMPX's cash runway extends into early ...

Biliary tract cancers, including cholangiocarcinoma and gallbladder carcinoma, represent a heterogeneous group of malignancies with rising global incidence and persistent dismal prognoses. Research in ...

Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ...

BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape Precision medicine has become a dominant theme in the treatment of biliary tract cancers (BTCs). Although prognosis ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old now impacted by the disease. However, despite this, knowledge about these ...

Compass Therapeutics (CMPX) is back on investors’ radar after fresh analysis of the biliary tract cancer market highlighted its lead candidate CTX-009 as a key emerging therapy in this growing ...

Compass Therapeutics, Inc. announced the dosing of the first patient in an Investigator Sponsored Trial (IST) at The University of Texas MD Anderson Cancer Center, evaluating tovecimig (CTX-009), a ...

The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption ...

One of the deadliest forms of cancer is biliary tract cancer. Only one in three patients diagnosed with the disease is operable. The rest must settle for life-sustaining treatment. The reason why this ...